Takeda, a Japanese pharma giant, is back on the acquisition warpath, paying $4 billion for a psoriasis treatment still in trial. There’s a risk the drug fails, but Takeda has cash and needs new money spinners, writes petesweeneypro
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Japan's Takeda to buy Nimbus' psoriasis drug for as much as $6 blnTakeda Pharmaceutical will buy U.S.-based Nimbus Therapeutics' experimental psoriasis drug for up to $6 billion, the Japanese drugmaker said on Tuesday, as it looks to cut reliance on treatments facing loss of patents.
Read more »
Japan's Takeda to buy psoriasis drug in up to $6 bln deal with NimbusJapan's Takeda Pharmaceutical said on Tuesday it would acquire Nimbus Therapeutics' drug being developed to treat autoimmune conditions such as psoriasis in up to $6 billion deal.
Read more »
Japanese company's lander rockets toward moon with UAE roverA Tokyo company is aiming for the moon with its own private lander. The lander blasted off from Cape Canaveral on Sunday atop a SpaceX rocket. On board is the United Arab Emirates' first lunar rover and a toylike robot from Japan that's designed to roll around in the gray lunar dust.
Read more »
Hayao Miyazaki’s next film hits Japanese theaters in 2023The long-in-the-works feature How Do You Live is slated to premiere on July 14th, 2023.
Read more »
Private Japanese moon lander snaps 1st photos in deep spaceThe Hakuto-R lander is coming online after its Dec. 11 launch.
Read more »
The Macallan Is Opening a Japanese-Inspired Tasting Menu Restaurant in ChicagoThe M Room will serve both food and drinks featuring the distillery's famed single malts.
Read more »